Tel:+86-21-51950625 51950635
Email us at sales@koutingchina.com
   
Products
b-AP15 
3E,​5E-​bis[(4-​nitrophenyl)methylene]-​1-​(1-​oxo-​2-​propen-​1-​yl)-​4-​piperidinone
(CAS 1009817-63-3)
Description:

Proteasome-associated deubiquitinases (DUBs) release ubiquitin from proteasome-targeted ubiquitinated proteins, regenerating free ubiquitin.b-AP15 is an inhibitor of ubiquitin-specific-processing protease 14 (USP14) and ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCHL5), two proteasome-associated DUBs. It inhibits DUB activity in purified 19S proteasomes with an IC50 value of 2.1 µM. It exhibits little or no activity against several other DUBs. Through its effects on USP14 and UCHL5, b-AP15 blocks tumor progression in vivo in mice and prevents organ infiltration in mouse models of myeloid leukemia. b-AP15 also renders tumor cells sensitive to TNF-mediated apoptosis by natural killer and T cells.

 

Product No. KT00232 
Product Name b-AP15 
Synonyms
Formal Name 3E,​5E-​bis[(4-​nitrophenyl)methylene]-​1-​(1-​oxo-​2-​propen-​1-​yl)-​4-​piperidinone
CAS Number 1009817-63-3
Molecular Formula C22H17N3O6
Formula Weight 419.4
Formulation A crystalline solid
Purity 98%min
Stability 2 years
Storage -20°C
Shipping USD45 for Europe and USA. No shipping charge once amount reach USD500
Quality Control HNMR,CNMR,LCMS,HPLC,IR,etc.
Price & Availability In Stock. Price Negotiated.
 
Not found? Pls contact with us for sourcing service.
Our contact email:sales@koutingchina.com
 
 
 
 
Related Products:

DUBs-IN-1

DUBs-IN-2

DUBs-IN-3

HBX 19818

ML-323

P 22077

P005091

PR-619

Order the product  * is required
Product:*
Your Name:*
Your Company:*
Add:
Tel:
Fax:
Web:
E-Mail:*
Your Demand :*

Products are for research use only. Not for human use. We do not sell to patients.
Copyrigh ©2009,China Kouting Group Limited All Rights Reserved. Supported by hxchem.net


products
Customer Service
Why Choose Us?
How to Order
How to Ship
How to Return
Frequently Asked Questions
Terms and Conditions
Email:sales@koutingchina.com
Skype: Notice